[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biomarin Pharmaceuticals (BMRN)

Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,564,904
  • Shares Outstanding, K 193,284
  • Annual Sales, $ 3,221 M
  • Annual Income, $ 348,900 K
  • EBIT $ 334 M
  • EBITDA $ 409 M
  • 60-Month Beta 0.25
  • Price/Sales 3.20
  • Price/Cash Flow 18.69
  • Price/Book 1.66

Options Overview Details

View History
  • Implied Volatility 37.98% (-0.91%)
  • Historical Volatility 45.58%
  • IV Percentile 42%
  • IV Rank 37.46%
  • IV High 55.46% on 02/23/26
  • IV Low 27.50% on 01/15/26
  • Expected Move (DTE 14) 3.03 (5.37%)
  • Put/Call Vol Ratio 0.09
  • Today's Volume 709
  • Volume Avg (30-Day) 1,338
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 36,824
  • Open Int (30-Day) 33,638
  • Expected Range 53.44 to 59.50

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.79
  • Number of Estimates 6
  • High Estimate $0.99
  • Low Estimate $0.62
  • Prior Year $1.25
  • Growth Rate Est. (year over year) -36.80%

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.26 +14.64%
on 05/18/26
57.51 -1.81%
on 05/29/26
+1.01 (+1.82%)
since 05/04/26
3-Month
49.26 +14.64%
on 05/18/26
61.97 -8.88%
on 03/10/26
-3.96 (-6.55%)
since 03/04/26
52-Week
49.26 +14.64%
on 05/18/26
66.28 -14.79%
on 02/24/26
+0.36 (+0.64%)
since 06/04/25

Most Recent Stories

More News
Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today

Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today

BMRN : 56.47 (+3.31%)
1 Small-Cap Stock with Solid Fundamentals and 2 We Find Risky

1 Small-Cap Stock with Solid Fundamentals and 2 We Find Risky

LMND : 51.57 (-2.07%)
BMRN : 56.47 (+3.31%)
AVO : 10.62 (-4.15%)
BioMarin Announces Positive Phase 3 Pivotal Study Results for VOXZOGO® (vosoritide) in Children with Hypochondroplasia

Study met primary endpoint, exceeding expectations with a highly statistically significant improvement in annualized growth velocity (AGV, change from baseline) of 2.33 cm/yr compared to placebo at week...

BMRN : 56.47 (+3.31%)
BioMarin Provides Update on Phase 3 Trial for BMN 401 in Children Aged 1-12 With ENPP1 Deficiency

ENERGY 3 study met 1 of 2 co-primary endpoints in children with ENPP1 deficiency

BMRN : 56.47 (+3.31%)
2 Cash-Producing Stocks Worth Investigating and 1 We Turn Down

2 Cash-Producing Stocks Worth Investigating and 1 We Turn Down

SEZL : 120.97 (+6.87%)
BMRN : 56.47 (+3.31%)
USFD : 82.20 (-1.15%)
BioMarin Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions

BioMarin Pharmaceutical’s Q1 Earnings Call: Our Top 5 Analyst Questions

BMRN : 56.47 (+3.31%)
BMRN Q1 Deep Dive: Amicus Acquisition, Pipeline Milestones, and Order Dynamics Shape Outlook

BMRN Q1 Deep Dive: Amicus Acquisition, Pipeline Milestones, and Order Dynamics Shape Outlook

BMRN : 56.47 (+3.31%)
BioMarin: Q1 Earnings Snapshot

BioMarin: Q1 Earnings Snapshot

BMRN : 56.47 (+3.31%)
BioMarin Pharmaceutical (NASDAQ:BMRN) Misses Q1 CY2026 Revenue Estimates

BioMarin Pharmaceutical (NASDAQ:BMRN) Misses Q1 CY2026 Revenue Estimates

BMRN : 56.47 (+3.31%)
BioMarin Reports First Quarter 2026 Financial and Operating Results

First Quarter 2026 Total Revenues Increased Year-over-year to $766 million

BMRN : 56.47 (+3.31%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for serious life-threatening medical conditions, mostly for children. The company's portfolio comprises seven marketed products namely, Aldurazyme, Naglazyme, Kuvan a rare genetic enzyme deficiency disorder),...

See More

Key Turning Points

3rd Resistance Point 59.25
2nd Resistance Point 58.15
1st Resistance Point 57.31
Last Price 56.47
1st Support Level 55.37
2nd Support Level 54.27
3rd Support Level 53.43

See More

52-Week High 66.28
Fibonacci 61.8% 59.77
Fibonacci 50% 57.77
Last Price 56.47
Fibonacci 38.2% 55.76
52-Week Low 49.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.